Published Date: 17 Mar 2023
FNB Fetal Radiology, ou FNB du National Board of Fetal Radiology, est un programme doctoral appelé FNB in Fetal Radiology.
Read Full NewsFor patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.
Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.
There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.
1.
Study confirms link between breast density, higher breast cancer risk
2.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
3.
How a California Oncologist Making $850k Spends Money
4.
Data indicate 1 in 3 US adults unaware of connection between HPV and cancers
5.
A new therapeutic approach could help tackle radiation resistance in childhood brain tumors
1.
Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment
2.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
3.
Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments
4.
From Bench to Bedside: The New Era of Lymphoma Treatment and Education
5.
A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation